Institutional Ownership Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB). We have compiled data on the 32 institutions that hold shares in the stock, with a total of 1.07 Million shares, which have been reported (via 13F filing form) to have a value of $2.24 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
K2 Principal Fund, L.P.
Toronto, A6 |
May 14, 2024 Q1 2024 |
327,503
shares
|
$684,481
0.27% of portfolio
|
Q1 2024
Added 7.51%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
200,281
shares
|
$418,587
0.0% of portfolio
|
Q1 2024
Reduced 7.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
174,602
shares
|
$364,918
0.0% of portfolio
|
Q1 2024
Added 1.91%
|
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
92,087
shares
|
$192,461
7.31% of portfolio
|
Q3 2023
Reduced 66.75%
|
|
|
Equitec Proprietary Markets, LLC
|
Apr 26, 2024 Q1 2024 |
82,727
shares
|
$172,899
0.12% of portfolio
|
Q3 2023
Added 34.7%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
43,800
shares
|
$91,542
0.0% of portfolio
|
Q1 2024
Added 14.96%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
41,188
shares
|
$86,082
0.0% of portfolio
|
Q1 2024
Added 86.98%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
24,563
shares
|
$51,336
0.0% of portfolio
|
Q1 2024
Reduced 16.19%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
23,500
shares
|
$49,115
0.0% of portfolio
|
Q1 2024
Added 1.29%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
21,104
shares
|
$44,107
0.0% of portfolio
|
Q1 2024
Reduced 26.64%
|
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
19,229
shares
|
$40,188
0.0% of portfolio
|
Q1 2024
Reduced 0.28%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
8,561
shares
|
$17,892
0.0% of portfolio
|
Q1 2024
Reduced 70.09%
|
|
|
Acadian Asset Management LLC
Boston, MA |
May 10, 2024 Q1 2024 |
3,589
shares
|
$7,501
0.0% of portfolio
|
Q1 2024
Reduced 25.06%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2024 Q1 2024 |
3,229
shares
|
$6,748
0.0% of portfolio
|
Q1 2024
Added 72.21%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
May 10, 2024 Q1 2024 |
1,767
shares
|
$3,693
0.0% of portfolio
|
Q1 2024
Added 0.51%
|
|
|
Cwm, LLC
|
Apr 05, 2024 Q1 2024 |
954
shares
|
$1,993
0.0% of portfolio
|
Q2 2023
Added 95300.0%
|
|
|
Aspire Private Capital, LLC
|
Apr 18, 2024 Q1 2024 |
800
shares
|
$1,672
0.0% of portfolio
|
Q4 2021
Added 100.0%
|
|
|
Covestor LTD
Boston, MA |
May 10, 2024 Q1 2024 |
226
shares
|
$472
0.0% of portfolio
|
Q4 2023
Added 19.58%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2024 Q1 2024 |
156
shares
|
$326
0.0% of portfolio
|
Q1 2024
Reduced 41.13%
|
|
|
Wells Fargo & Company
San Francisco, CA |
May 10, 2024 Q1 2024 |
55
shares
|
$114
0.0% of portfolio
|
Q4 2023
Added 3.77%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
54
shares
|
$112
0.0% of portfolio
|
Q1 2024
Reduced 12.9%
|
|
|
Private Wealth Management Group, LLC
Princeton, NJ |
Apr 30, 2024 Q1 2024 |
42
shares
|
$87
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
18
shares
|
$37
0.0% of portfolio
|
Q1 2024
Added 50.0%
|
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
14
shares
|
$29
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Sachetta, LLC
Lynnfield, MA |
May 01, 2024 Q1 2024 |
14
shares
|
$29
0.0% of portfolio
|
Q4 2023
New holding
|
|